Ogden Christopher 4

4 · CytomX Therapeutics, Inc. · Filed Feb 4, 2026

AI-generated summary of this filing

Updated Feb 4, 2026

CytomX (CTMX) CFO Christopher Ogden Receives RSU Awards

What Happened

CytomX CFO Christopher Ogden received equity awards on 2026-02-02 consisting of 90,000 shares (RSUs) and 325,000 derivative awards (total 415,000). All awards were granted at $0.00 per share (i.e., no cash paid at grant).
Part of the 325,000 derivative award includes 239,987 RSUs; the remaining portion is subject to a four-year monthly vesting schedule (1/48th vesting each month beginning 2026-02-02). A separate RSU tranche vests 1/3 annually on March 15, with the first 1/3 vesting March 15, 2027, subject to continued service.

Key Details

Transaction date: 2026-02-02; Filing date: 2026-02-04 (timely).
Price: $0.00 per share; total immediate cash value at grant: $0.
Awards: 90,000 RSUs + 325,000 derivative awards = 415,000 total; F2 notes 239,987 of the 325,000 are RSUs; F3 describes 1/48th monthly vesting for the option portion.
Shares owned after the transaction: not specified in the provided filing excerpt.
Footnotes: F1 = RSUs with 1/3 annual vesting on March 15 (first vest 3/15/2027); F2 = includes 239,987 RSUs; F3 = option-style vesting of 1/48th per month from 2/2/2026 to full vest at four years.
Filing timeliness: appears timely (filed two days after transaction).

Context

These are compensation grants (awards), not open-market purchases or sales. RSUs convert to common shares only as they vest; option-style awards vest over time and must generally be exercised to become shares.
Grants like this are common for executive compensation and do not by themselves indicate an intent to buy or sell stock in the market.

Form 4

Period: 2026-02-02

Chief Financial Officer

Transactions

Award
Common Stock
[F1][F2]
2026-02-02+90,000→ 316,271 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-02+325,000→ 325,000 total
Exercise: $6.09Exp: 2036-02-01→ Common Stock (325,000 underlying)

Footnotes (3)

[F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2027, subject to the Reporting Person continuing as a service provider through each such date.
[F2]Includes 239,987 RSUs.
[F3]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Signature

/s/ Christopher Ogden|2026-02-04

1 file